PMID- 29530791 OWN - NLM STAT- MEDLINE DCOM- 20190729 LR - 20190729 IS - 1873-6300 (Electronic) IS - 0891-0618 (Linking) VI - 91 DP - 2018 Sep TI - Overexpression of miR-219 promotes differentiation of human induced pluripotent stem cells into pre-oligodendrocyte. PG - 8-16 LID - S0891-0618(17)30209-0 [pii] LID - 10.1016/j.jchemneu.2018.03.001 [doi] AB - Oligodendrocytes play critical roles in the central nervous system (CNS) thorough producing myelin sheaths around axons. There are a variety of approaches to produce oligodendrocytes in vitro and in vivo which are a subject of interest in many studies. A new approach to induce this differentiation is using microRNA 219 (miR-219). However, this new approach suffers from a lack of studies regarding the effect of miR-219 on differentiating human induced pluripotent stem cells (hiPSCs) to oligodendrocytes. This study aimed to assess the impact of miR-219-overexpression on hiPSCs. Initially, hiPSCs were induced with basic fibroblast growth factor (bFGF), epidermalgrowth factor (EGF) and platelet-derived growth factor (PDGF)-AA, then, miR-219- green fluorescent protein (GFP)-expressing lentiviruses were utilized for cell infection. Microscopic observation revealed significant morphological changes and data obtained from quantitative reverse transcription PCR and immunofluorescence analysis of differentiated cells showed that the expression of various oligodendrocyte stage-specific markers such as Nestin, Olig2, Sox10, PDGFRalpha, A2B5, O4, and MBP increased. In addition, higher expressions of pre-oligodendrocyte markers were detected in the cells transduced with miR-219 lentivirus in comparison with the cells treated with triiodothyronine (T3). These results suggest that overexpression of miR-219 promotes differentiation of hiPSCs to pre-oligodendrocyte cells, providing a potential source for cell therapy by replacing and restoring the lost cell function in neurodegenerative and demyelinating diseases. CI - Copyright (c) 2018. Published by Elsevier B.V. FAU - Nazari, Bahareh AU - Nazari B AD - Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran. FAU - Soleimani, Masoud AU - Soleimani M AD - Department of Hematology, Faculty of Medical Sciences, TarbiatModares University, Tehran, Iran. FAU - Ebrahimi-Barough, Somayeh AU - Ebrahimi-Barough S AD - Department of Tissue Engineering and Applied Cell Sciences, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran. FAU - Enderami, Seyed Ehsan AU - Enderami SE AD - Stem Cell Technology Research Center, Tehran, Iran. FAU - Kazemi, Mansure AU - Kazemi M AD - Department of Tissue Engineering and Applied Cell Sciences, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran. FAU - Negahdari, Babak AU - Negahdari B AD - Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran. FAU - Sadroddiny, Esmaeil AU - Sadroddiny E AD - Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: sadroddiny@sina.tums.ac.ir. FAU - Ai, Jafar AU - Ai J AD - Department of Tissue Engineering and Applied Cell Sciences, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: Jafar_ai@tums.ac.ir. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20180309 PL - Netherlands TA - J Chem Neuroanat JT - Journal of chemical neuroanatomy JID - 8902615 RN - 0 (MIRN219 microRNA, human) RN - 0 (MicroRNAs) MH - Cell Differentiation/*genetics MH - Humans MH - Induced Pluripotent Stem Cells/*cytology/metabolism MH - MicroRNAs/*biosynthesis MH - Oligodendrocyte Precursor Cells/*cytology/metabolism MH - Oligodendroglia/*cytology/metabolism OTO - NOTNLM OT - Differentiation OT - Induced pluripotent stem cells OT - Oligodendrocyte OT - miR-219 EDAT- 2018/03/14 06:00 MHDA- 2019/07/30 06:00 CRDT- 2018/03/14 06:00 PHST- 2017/10/07 00:00 [received] PHST- 2018/03/04 00:00 [revised] PHST- 2018/03/05 00:00 [accepted] PHST- 2018/03/14 06:00 [pubmed] PHST- 2019/07/30 06:00 [medline] PHST- 2018/03/14 06:00 [entrez] AID - S0891-0618(17)30209-0 [pii] AID - 10.1016/j.jchemneu.2018.03.001 [doi] PST - ppublish SO - J Chem Neuroanat. 2018 Sep;91:8-16. doi: 10.1016/j.jchemneu.2018.03.001. Epub 2018 Mar 9.